{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T04:01:44Z","timestamp":1747713704111,"version":"3.40.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T00:00:00Z","timestamp":1747612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Thrombotic thrombocytopenic purpura (TTP) is an uncommon and life-threatening disorder caused by a deficiency of ADAMTS-13, and eventually leads to microangiopathic hemolytic anemia, severe thrombocytopenia, and organ damages. Acute TTP events could be triggered by infections, or inflammations in the context of ADAMTS-13 deficiency. Recently, several case reports have indicated an association between diabetic ketoacidosis (DKA) and TTP. Here, we present a case with the concomitant presentation of DKA and TTP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>A 37-year-old male with diabetes mellitus presented with typical symptoms of diabetic ketoacidosis. He was managed with an insulin pump and intravenous fluids. However, he developed seizure and progressed to coma, his rapidly deteriorating condition necessitated continuous renal replacement therapy, intubation, and inotropic support. Laboratory data indicated hemolytic anemia and thrombocytopenia, and a blood smear revealed schistocytes. The PLASMIC score was 5, and ADAMTS-13 activity was 2%. The patient was diagnosed with TTP and treated with therapeutic plasma exchange, steroids, and rituximab. His platelet count stabilized above 150,000\/\u00b5L, and ADAMTS-13 activity progressively improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This case report emphasizes the concurrence of DKA and iTTP, presenting the rare complication of acute renal failure in TTP. TTP is a rare and serious disease that requires prompt recognition and management. Concurrent conditions should be considered when calculating prediction scores such as the PLASMIC and French scores.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12959-025-00740-w","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:30:46Z","timestamp":1747639846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review"],"prefix":"10.1186","volume":"23","author":[{"given":"Geng-Hao","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei-Hwa","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-5847","authenticated-orcid":false,"given":"Tien-Jyun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4121-019X","authenticated-orcid":false,"given":"Sheng-Chieh","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,19]]},"reference":[{"key":"740_CR1","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","volume":"129","author":"BS Joly","year":"2017","unstructured":"Joly BS, Coppo P, Veyradier A. Thrombotic thrombocytopenic purpura. Blood. 2017;129:2836\u201346.","journal-title":"Blood"},{"key":"740_CR2","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, L\u00e4mmle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020.","journal-title":"Nat Rev Dis Primers"},{"key":"740_CR3","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1111\/jth.15006","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18:2486\u201395.","journal-title":"J Thromb Haemost"},{"key":"740_CR4","doi-asserted-by":"crossref","unstructured":"Sukumar S, L\u00e4mmle B, Cataland SR. Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management. J Clin Med 2021, 10.","DOI":"10.3390\/jcm10030536"},{"key":"740_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1182\/blood-2017-04-636431","volume":"130","author":"JE Sadler","year":"2017","unstructured":"Sadler JE. Pathophysiology of thrombotic thrombocytopenic purpura. Blood. 2017;130:1181\u20138.","journal-title":"Blood"},{"key":"740_CR6","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1111\/jth.15010","volume":"18","author":"XL Zheng","year":"2020","unstructured":"Zheng XL, Vesely SK, Cataland SR, Coppo P, Geldziler B, Iorio A, Matsumoto M, Mustafa RA, Pai M, Rock G, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020;18:2496\u2013502.","journal-title":"J Thromb Haemost"},{"key":"740_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/bjh.19026","volume":"203","author":"M Scully","year":"2023","unstructured":"Scully M, Rayment R, Clark A, Westwood JP, Cranfield T, Gooding R, Bagot CN, Taylor A, Sankar V, Gale D, et al. A British society for haematology guideline: diagnosis and management of thrombotic thrombocytopenic purpura and thrombotic microangiopathies. Br J Haematol. 2023;203:546\u201363.","journal-title":"Br J Haematol"},{"key":"740_CR8","doi-asserted-by":"publisher","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","volume":"3","author":"E Mariotte","year":"2016","unstructured":"Mariotte E, Azoulay E, Galicier L, Rondeau E, Zouiti F, Boisseau P, Poullin P, de Maistre E, Prov\u00f4t F, Delmas Y, et al. Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French National registry for thrombotic microangiopathy. Lancet Haematol. 2016;3:e237\u2013245.","journal-title":"Lancet Haematol"},{"key":"740_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/imj.12935","volume":"46","author":"P Blombery","year":"2016","unstructured":"Blombery P, Kivivali L, Pepperell D, McQuilten Z, Engelbrecht S, Polizzotto MN, Phillips LE, Wood E, Cohney S. Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry. Intern Med J. 2016;46:71\u20139.","journal-title":"Intern Med J"},{"key":"740_CR10","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.2337\/dci24-0032","volume":"47","author":"GE Umpierrez","year":"2024","unstructured":"Umpierrez GE, Davis GM, ElSayed NA, Fadini GP, Galindo RJ, Hirsch IB, Klonoff DC, McCoy RG, Misra S, Gabbay RA, et al. Hyperglycemic crises in adults with diabetes: A consensus report. Diabetes Care. 2024;47:1257\u201375.","journal-title":"Diabetes Care"},{"key":"740_CR11","first-page":"40","volume":"12","author":"KP Patra","year":"2011","unstructured":"Patra KP, Scott LK. Diabetic ketoacidosis preceding thrombocytopenia associated multiple organ failure in a child. Jop. 2011;12:40\u20133.","journal-title":"Jop"},{"key":"740_CR12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s13312-013-0175-0","volume":"50","author":"MR Khan","year":"2013","unstructured":"Khan MR, Maheshwari PK, Haque A. Thrombotic microangiopathic syndrome: a novel complication of diabetic ketoacidosis. Indian Pediatr. 2013;50:697\u20139.","journal-title":"Indian Pediatr"},{"key":"740_CR13","doi-asserted-by":"crossref","unstructured":"Merrick V, Malik M, Vaidya M. Abstract 256: Diabetic ketoacidosis (DKA) Preceding thrombocytopenia associated with acute renal failure and pancreatic enzyme elevation. Pediatr Crit Care Med 2014, 15.","DOI":"10.1097\/01.pcc.0000448982.07798.36"},{"key":"740_CR14","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/ped.12780","volume":"58","author":"T Alsaied","year":"2016","unstructured":"Alsaied T, Goldstein SL, Kaddourah A, Poynter SE. Thrombocytopenia-associated multi-organ failure caused by diabetic ketoacidosis. Pediatr Int. 2016;58:232\u20134.","journal-title":"Pediatr Int"},{"key":"740_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ccr3.587","volume":"4","author":"R Kumar","year":"2016","unstructured":"Kumar R, McSharry B, Bradbeer P, Wiltshire E, Jefferies C. Thrombocytopenia-associated multiorgan failure occurring in an infant at the onset of type 1 diabetes successfully treated with fresh frozen plasma. Clin Case Rep. 2016;4:671\u20134.","journal-title":"Clin Case Rep"},{"key":"740_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4103\/2277-9175.225928","volume":"7","author":"N Mostofizadeh","year":"2018","unstructured":"Mostofizadeh N, Arefnia S, Hashemipour M, Dehkordi EH. Thrombotic thrombocytopenic Purpura in a child with diabetic ketoacidosis. Adv Biomed Res. 2018;7:33.","journal-title":"Adv Biomed Res"},{"key":"740_CR17","first-page":"SD01","volume":"14","author":"BKG Meenakshi Dadwal","year":"2020","unstructured":"Meenakshi Dadwal BKG. Parveen Kumar Antil, Baljeet Maini: thrombocytopenia associated Multi-Organ failure: A fatal complication of diabetes ketoacidosis. J Clin Diagn Res. 2020;14:SD01\u20132.","journal-title":"J Clin Diagn Res"},{"key":"740_CR18","first-page":"22","volume":"18","author":"S Ponnambalam","year":"2020","unstructured":"Ponnambalam S, Varadarajan P, Subramani S, Subramanian R. Unusual complication in a child with diabetic ketoacidosis. Pediatr Oncall J. 2020;18:22\u20134.","journal-title":"Pediatr Oncall J"},{"key":"740_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jca.21751","volume":"35","author":"D Hermelin","year":"2020","unstructured":"Hermelin D, Blackall D. Successful plasma exchange in a 34-year\u2010old woman with diabetic ketoacidosis and a thrombotic microangiopathy. J Clin Apheresis. 2020;35:62\u20135.","journal-title":"J Clin Apheresis"},{"key":"740_CR20","doi-asserted-by":"crossref","unstructured":"Jackson LJ, Fischer H, Abdelsayed N, Carter M. Diabetic ketoacidosis: possible cause of thrombotic thrombocytopenic purpura. Cureus 2021, 13.","DOI":"10.7759\/cureus.18017"},{"key":"740_CR21","doi-asserted-by":"crossref","unstructured":"Nwankwo CI, Samuels KA, Abung A, Oshikoya AF, Waqar D, Omole AE. Diabetic ketoacidosis complicated by thrombotic thrombocytopenic purpura: A rare association. Cureus 2023, 15.","DOI":"10.7759\/cureus.37983"},{"key":"740_CR22","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","volume":"4","author":"PK Bendapudi","year":"2017","unstructured":"Bendapudi PK, Hurwitz S, Fry A, Marques MB, Waldo SW, Li A, Sun L, Upadhyay V, Hamdan A, Brunner AM. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study. Lancet Haematol. 2017;4:e157\u201364.","journal-title":"Lancet Haematol"},{"key":"740_CR23","doi-asserted-by":"publisher","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","volume":"5","author":"P Coppo","year":"2010","unstructured":"Coppo P, Schwarzinger M, Buffet M, Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS ONE. 2010;5:e10208.","journal-title":"PLoS ONE"},{"key":"740_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/jth.13882","volume":"16","author":"A Li","year":"2018","unstructured":"Li A, Khalighi PR, Wu Q, Garcia DA. External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment. J Thromb Haemost. 2018;16:164\u20139.","journal-title":"J Thromb Haemost"},{"key":"740_CR25","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/jca.22068","volume":"38","author":"JA Lee","year":"2023","unstructured":"Lee JA, Lin MH, Kang CM, Chuang MK, Fung CKB, Lo SC. A validation and modification of PLASMIC score by adjusting the criteria of mean corpuscular volume and international normalized ratio. J Clin Apher. 2023;38:582\u20139.","journal-title":"J Clin Apher"},{"key":"740_CR26","doi-asserted-by":"crossref","unstructured":"Lee C-H, Huang Y-C, Li S-S, Hsu Y-T, Chen Y-P, Chen T-Y. Application of PLASMIC score in risk prediction of thrombotic thrombocytopenic purpura: Real-World experience from a tertiary medical center in Taiwan. Front Med 2022, 9.","DOI":"10.3389\/fmed.2022.893273"},{"key":"740_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.thromres.2018.10.010","volume":"172","author":"N Tang","year":"2018","unstructured":"Tang N, Wang X, Li D, Sun Z. Validation of the PLASMIC score, a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis, in Chinese patients. Thromb Res. 2018;172:9\u201313.","journal-title":"Thromb Res"},{"key":"740_CR28","doi-asserted-by":"publisher","first-page":"e33029","DOI":"10.1371\/journal.pone.0033029","volume":"7","author":"M Matsumoto","year":"2012","unstructured":"Matsumoto M, Bennett CL, Isonishi A, Qureshi Z, Hori Y, Hayakawa M, Yoshida Y, Yagi H, Fujimura Y. Acquired idiopathic ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in a population from Japan. PLoS ONE. 2012;7:e33029.","journal-title":"PLoS ONE"},{"key":"740_CR29","first-page":"731","volume":"98","author":"HM Tsai","year":"2007","unstructured":"Tsai HM. The kidney in thrombotic thrombocytopenic purpura. Minerva Med. 2007;98:731\u201347.","journal-title":"Minerva Med"},{"key":"740_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/jth.12826","volume":"13","author":"L Zafrani","year":"2015","unstructured":"Zafrani L, Mariotte E, Darmon M, Canet E, Merceron S, Boutboul D, Veyradier A, Galicier L, Azoulay E. Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity. J Thromb Haemost. 2015;13:380\u20139.","journal-title":"J Thromb Haemost"},{"key":"740_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1056\/NEJMoa1806311","volume":"380","author":"M Scully","year":"2019","unstructured":"Scully M, Cataland SR, Peyvandi F, Coppo P, Kn\u00f6bl P, Kremer Hovinga JA, Metjian A, de la Rubia J, Pavenski K, Callewaert F, et al. Caplacizumab treatment for acquired thrombotic thrombocytopenic Purpura. N Engl J Med. 2019;380:335\u201346.","journal-title":"N Engl J Med"},{"key":"740_CR32","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/jth.15363","volume":"19","author":"J Schofield","year":"2021","unstructured":"Schofield J, Shaw RJ, Lester W, Thomas W, Toh CH, Dutt T. Intracranial hemorrhage in immune thrombotic thrombocytopenic purpura treated with Caplacizumab. J Thromb Haemost. 2021;19:1922\u20135.","journal-title":"J Thromb Haemost"},{"issue":"Pt 2","key":"740_CR33","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/eye.1993.52","volume":"7","author":"AH Barnett","year":"1993","unstructured":"Barnett AH. Origin of the microangiopathic changes in diabetes. Eye (Lond). 1993;7(Pt 2):218\u201322.","journal-title":"Eye (Lond)"},{"key":"740_CR34","first-page":"211","volume":"315","author":"SH James","year":"1998","unstructured":"James SH, Meyers AM. Microangiopathic hemolytic Anemia as a complication of diabetes mellitus. Am J Med Sci. 1998;315:211\u20135.","journal-title":"Am J Med Sci"},{"key":"740_CR35","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1182\/blood-2015-01-620278","volume":"125","author":"Y Xiang","year":"2015","unstructured":"Xiang Y, Cheng J, Wang D, Hu X, Xie Y, Stitham J, Atteya G, Du J, Tang WH, Lee SH, et al. Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor. Blood. 2015;125:3377\u201387.","journal-title":"Blood"},{"key":"740_CR36","doi-asserted-by":"publisher","first-page":"e310","DOI":"10.1016\/j.thromres.2010.02.013","volume":"125","author":"S Taniguchi","year":"2010","unstructured":"Taniguchi S, Hashiguchi T, Ono T, Takenouchi K, Nakayama K, Kawano T, Kato K, Matsushita R, Nagatomo M, Nakamura S, et al. Association between reduced ADAMTS13 and diabetic nephropathy. Thromb Res. 2010;125:e310\u2013316.","journal-title":"Thromb Res"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00740-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00740-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00740-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:30:51Z","timestamp":1747639851000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00740-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["740"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00740-w","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,19]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to submission this manuscript to Thrombosis Journal. The results\/data\/figures in this manuscript have not been published elsewhere, nor are they under consideration (from you or one of your Contributing Authors) by another publisher.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"50"}}